Skip to main content

Peer Review reports

From: Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol

Original Submission
14 Feb 2024 Submitted Original manuscript
29 Feb 2024 Author responded Author comments - Alexandra Calmy
5 Mar 2024 Author responded Author comments - Alexandra Calmy
Resubmission - Version 2
29 Feb 2024 Submitted Manuscript version 2
Publishing
5 Mar 2024 Editorially accepted
19 Mar 2024 Article published 10.1186/s12879-024-09192-5

You can find further information about peer review here.

Back to article page